BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, September 23, 2023
Home » Blogs » BioWorld MedTech Perspectives » Med-tech from the battlefield

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Med-tech from the battlefield

Aug. 12, 2013
By Amanda Pedersen
No Comments

wounded-warriorsA decade ago it would have been hard to imagine a bioabsorbable tissue-lined stent graft capable of treating blood vessels that have been ripped apart by a bomb, or a spray-on solution that would promote the regrowth of your own skin after a traumatic injury or burn, or even a portable machine that could treat deadly infections like sepsis in much the same way that dialysis machines treat kidney failure. But today these innovations and many more are being developed to treat wounded warriors and will someday be used not just on the battlefield but in civilian hospitals as well. This week Medical Device Daily will be reporting on the various ways that combat needs have influenced R&D for medical technology in a three-part series. Of course this is not a new phenomenon but something that has occurred throughout history, as far back as World War I and beyond. Probably for as long as battles have existed, war wounds have played a role in advancing medicine on the homefront. But what has changed is the types of injuries that combat medics and surgeons have had to deal with during these two most recent conflicts overseas, primarily because the military now has such advanced, high-tech body armor and armored vehicles, that soldiers are now surviving blasts that otherwise might have killed them. That’s why the majority of injuries these wounded warriors suffer from have been quite traumatic and life-altering, like amputations, paralysis and severe burns. As a military spouse I’m sensitive to the sacrifice that these wounded warriors have made and I am grateful that organizations like the Armed Forces Institute of Regenerative Medicine (AFIRM) at Fort Detrick, Maryland have been able to fund so many R&D projects to advance combat treatment. My fear is that as the U.S. pulls out of Iraq and Afghanistan the government will also stop funding this type of research. During an interview with Maj. Louis Alvarez of the AFIRM, he expressed similar concerns. “We want to maintain awareness and visibility of these injuries that will be lifelong and traumatic,” he said. “... We should maintain as much momentum as possible,” on these fronts.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 22, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 22, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • Illustration of Alzheimer’s in the brain.

    Study identifies cause of death for Alzheimer’s neurons

    BioWorld
    By creating a new mouse model of Alzheimer’s disease that better recapitulated how the disease plays out in humans, investigators at KU Leuven have gained new...
  • New NLRP3 inflammasome inhibitors named in PTC Therapeutics patent

    BioWorld Science
    PTC Therapeutics Inc. has patented new NLRP3 inflammasome inhibitors reported to be useful...
BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing